<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kim T</submitter><funding>Bristol-Myers Squibb Company | Bristol-Myers Squibb Canada</funding><funding>NCATS NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Center for Research Resources</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases</funding><funding>NHGRI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Human Genome Research Institute</funding><funding>NIAMS NIH HHS</funding><funding>Arthritis National Research Foundation</funding><pagination>2150</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10923805</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Fine-mapping and functional studies implicate rs117701653, a non-coding single nucleotide polymorphism in the CD28/CTLA4/ICOS locus, as a risk variant for rheumatoid arthritis and type 1 diabetes. Here, using DNA pulldown, mass spectrometry, genome editing and eQTL analysis, we establish that the disease-associated risk allele is functional, reducing affinity for the inhibitory chromosomal regulator SMCHD1 to enhance expression of inducible T-cell costimulator (ICOS) in memory CD4&lt;sup>+&lt;/sup> T cells from healthy donors. Higher ICOS expression is paralleled by an increase in circulating T peripheral helper (Tph) cells and, in rheumatoid arthritis patients, of blood and joint fluid Tph cells as well as circulating plasmablasts. Correspondingly, ICOS ligation and carriage of the rs117701653 </pubmed_abstract><journal>Nature communications</journal><pubmed_title>Non-coding autoimmune risk variant defines role for ICOS in T peripheral helper cell development.</pubmed_title><pmcid>PMC10923805</pmcid><funding_grant_id>R01AR065538</funding_grant_id><funding_grant_id>P30 AR070549</funding_grant_id><funding_grant_id>AR078769</funding_grant_id><funding_grant_id>P30AR069625</funding_grant_id><funding_grant_id>R01 AR073201</funding_grant_id><funding_grant_id>R01AI024717</funding_grant_id><funding_grant_id>R01 AR077607</funding_grant_id><funding_grant_id>R01 HG010730</funding_grant_id><funding_grant_id>R01 AR075906</funding_grant_id><funding_grant_id>R01AR063759</funding_grant_id><funding_grant_id>R01 NS099068</funding_grant_id><funding_grant_id>K08AR072791</funding_grant_id><funding_grant_id>P30AR070253</funding_grant_id><funding_grant_id>R01 AR073228</funding_grant_id><funding_grant_id>R01AR073228</funding_grant_id><funding_grant_id>R01 AR065538</funding_grant_id><funding_grant_id>P30 AR069625</funding_grant_id><funding_grant_id>IM101-835</funding_grant_id><funding_grant_id>UL1TR002541</funding_grant_id><funding_grant_id>R01AR077607</funding_grant_id><funding_grant_id>R01 AR063759</funding_grant_id><funding_grant_id>R01AR075906</funding_grant_id><funding_grant_id>U01AI130830</funding_grant_id><funding_grant_id>UL1 TR002541</funding_grant_id><funding_grant_id>P30AR072577</funding_grant_id><funding_grant_id>U01 AI130830</funding_grant_id><funding_grant_id>T32 AR007530</funding_grant_id><funding_grant_id>T32 AR007611</funding_grant_id><funding_grant_id>P30 AR072577</funding_grant_id><funding_grant_id>R01HG010730</funding_grant_id><funding_grant_id>R01AR073201</funding_grant_id><funding_grant_id>R01 AI024717</funding_grant_id><funding_grant_id>P30 AR070253</funding_grant_id><funding_grant_id>K08 AR072791</funding_grant_id><funding_grant_id>R01NS099068</funding_grant_id><funding_grant_id>R01 AR078769</funding_grant_id><pubmed_authors>Hackert N</pubmed_authors><pubmed_authors>Chiu DJ</pubmed_authors><pubmed_authors>Baglaenko Y</pubmed_authors><pubmed_authors>Weirauch MT</pubmed_authors><pubmed_authors>Rao DA</pubmed_authors><pubmed_authors>Raychaudhuri S</pubmed_authors><pubmed_authors>Nigrovic PA</pubmed_authors><pubmed_authors>Laza-Briviesca R</pubmed_authors><pubmed_authors>Westra HJ</pubmed_authors><pubmed_authors>Darbousset R</pubmed_authors><pubmed_authors>Sparks JA</pubmed_authors><pubmed_authors>Aguiar VRC</pubmed_authors><pubmed_authors>Kim T</pubmed_authors><pubmed_authors>Koh B</pubmed_authors><pubmed_authors>Wang Q</pubmed_authors><pubmed_authors>Martinez-Bonet M</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Gutierrez-Arcelus M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Non-coding autoimmune risk variant defines role for ICOS in T peripheral helper cell development.</name><description>Fine-mapping and functional studies implicate rs117701653, a non-coding single nucleotide polymorphism in the CD28/CTLA4/ICOS locus, as a risk variant for rheumatoid arthritis and type 1 diabetes. Here, using DNA pulldown, mass spectrometry, genome editing and eQTL analysis, we establish that the disease-associated risk allele is functional, reducing affinity for the inhibitory chromosomal regulator SMCHD1 to enhance expression of inducible T-cell costimulator (ICOS) in memory CD4&lt;sup>+&lt;/sup> T cells from healthy donors. Higher ICOS expression is paralleled by an increase in circulating T peripheral helper (Tph) cells and, in rheumatoid arthritis patients, of blood and joint fluid Tph cells as well as circulating plasmablasts. Correspondingly, ICOS ligation and carriage of the rs117701653 </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-15T14:02:14.312Z</modification><creation>2024-11-09T19:15:22.647Z</creation></dates><accession>S-EPMC10923805</accession><cross_references><pubmed>38459032</pubmed><doi>10.1038/s41467-024-46457-8</doi></cross_references></HashMap>